SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-242331
Filing Date
2017-07-31
Accepted
2017-07-31 16:02:58
Documents
56
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d425586d10q.htm 10-Q 763816
2 EX-31.1 d425586dex311.htm EX-31.1 6168
3 EX-31.2 d425586dex312.htm EX-31.2 6203
4 EX-32.1 d425586dex321.htm EX-32.1 4524
11 GRAPHIC g425586g79j81.jpg GRAPHIC 118693
  Complete submission text file 0001193125-17-242331.txt   3948648

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ziop-20170630.xml EX-101.INS 527444
6 XBRL TAXONOMY EXTENSION SCHEMA ziop-20170630.xsd EX-101.SCH 43623
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ziop-20170630_cal.xml EX-101.CAL 41702
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ziop-20170630_def.xml EX-101.DEF 196022
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ziop-20170630_lab.xml EX-101.LAB 367916
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ziop-20170630_pre.xml EX-101.PRE 273576
Mailing Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129
Business Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129 617-259-1970
ZIOPHARM ONCOLOGY INC (Filer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33038 | Film No.: 17992990
SIC: 2834 Pharmaceutical Preparations